Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
01/07/2009 | CN101337965A Method for preparing camptothecin derivates |
01/07/2009 | CN101337959A 2-amino-N-oxybenzamidecompounds with insecticidal activity |
01/07/2009 | CN101337934A Method for preparing fluoroquinolone compound |
01/07/2009 | CN100448875C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
01/07/2009 | CN100448874C N-aroyl cyclic amines |
01/07/2009 | CN100448873C Cycloalkyl derivatives of 3-hydroxy-4-pyridinones |
01/07/2009 | CN100448870C 2-aminoquinoline derivative |
01/07/2009 | CN100448869C Anilinopyrazole derivatives useful for the treatment of diabetes |
01/07/2009 | CN100448868C Tri-substituted heteroaryls and methods of making and using the same |
01/07/2009 | CN100448850C Amino 1, 3, 5-triazines n-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof and their use as herbicides and plant growth regulators |
01/07/2009 | CN100448844C Inhibitors of histone deacetylase |
01/06/2009 | US7473795 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors |
01/06/2009 | US7473701 Substituted indazoles, compositions containing them, method of production and use |
01/06/2009 | US7473698 Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof |
01/06/2009 | US7473695 4-imidazolin-2-one compounds |
01/06/2009 | US7473693 pyrazine carboxamide compounds of sub-micron size; improve bioavailibility/absorption, exhibit no increase in size upon storage in the aqueous medium; N-(1-piperidinyl)-5,6-diphenyl-2-pyrazinecarboxamide; using a precipitation process without the need for water-immiscible solvent; obesity |
01/06/2009 | US7473692 Sulfonamide derivatives as D3-receptor ligands |
01/06/2009 | US7473691 Pyrazole compounds useful as protein kinase inhibitors |
01/06/2009 | US7473686 Thrombopoietin mimetics |
01/06/2009 | CA2494321C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
01/06/2009 | CA2478374C N3 alkylated benzimidazole derivatives as mek inhibitors |
01/06/2009 | CA2421008C Substituted heterocyclic compounds for treating multidrug resistance |
01/06/2009 | CA2414095C Novel compounds |
01/06/2009 | CA2369504C Pyrazole compositions useful as inhibitors of erk |
01/06/2009 | CA2295446C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
01/06/2009 | CA2227851C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
01/06/2009 | CA2216546C 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity |
01/02/2009 | DE60224401T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure |
01/01/2009 | US20090005570 Method for preparing 2- (2-pyridinylmethylsulfinyl) benzimidazoles |
01/01/2009 | US20090005568 Substituted 2-aminothiazoles for treating neurodegenerative diseases |
01/01/2009 | US20090005567 Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo (5,6)-cyclohepta-(1,2b) -pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester (loratadine) |
01/01/2009 | US20090005419 Organic Compounds |
01/01/2009 | US20090005418 such as 2-benzyl-5-(2,5-difluorophenyl)-3-phenyl-2,3-dihydroisoxazole, useful for treating cellular proliferative diseases such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation in mammals |
01/01/2009 | US20090005417 Substituted Indazolyl Sulfonamide and 2,3-Dihydro-Indolyl Sulfonamide Compounds, their Preparation and Use in Medicaments |
01/01/2009 | US20090005416 Benzimidazole derivatives |
01/01/2009 | US20090005415 1,2-Diarylimidazoles for Use as Cb1 Modulators |
01/01/2009 | US20090005410 N-(4-Chloro-2-[1,2,3]triazolo[4,5-b]pyridin-1-yl-phenyl)-4-(1-hydroxy-1-methyl-ethyl)-benzene-sulfonamide sodium salt, used as chemokine receptors antagonists, useful for treating inflammation |
01/01/2009 | US20090005407 Particulate (3'-chlorobiphenyl-4-yl)(1-(pyrimidin-2-yl)piperidin-4-yl)methanone and methods of its use |
01/01/2009 | US20090005404 Pyridylsulfonamido pyrimidines for treating diabetic nephropathy |
01/01/2009 | US20090005403 Alkinyl-Oxypyrimidines Used in the Form of Pesticides |
01/01/2009 | US20090005399 Substituted Imidazo[2,1-b]thiazole Compounds and Uses Thereof |
01/01/2009 | US20090005397 Substituted Oxindol Derivatives and Medicaments Containing the Same |
01/01/2009 | US20090005393 Pyridine and Pyrimidine Derivatives as Inhibitors of Histone Deacetylase |
01/01/2009 | US20090005392 Crystal of 6-[4-(4-pyridylamino) phenyl]-4,5-dihydro-3(2h-pyridazinone hydrochloride trihydrate |
01/01/2009 | US20090005380 Cyclohexyl derivatives |
01/01/2009 | US20090005374 Imidazopyridinyl thiazolyl histone deacetylase inhibitors |
01/01/2009 | US20090005365 Therapeutic pyrazolonaphthyridine derivatives |
01/01/2009 | US20090005364 Azole Derivatives With Antimuscarinic Activity |
01/01/2009 | US20090005363 Organic Compounds |
01/01/2009 | US20090005355 Piperidine Compound and Process for Preparing the Same |
01/01/2009 | US20090005354 New Amino Derivatives and Their Use as Pharmaceuticals |
01/01/2009 | US20090005353 used in treating and/or preventing cardiovascular disorders, inflammatory diseases, Alzheimer's disease, dyslipidemia and metabolic syndrome |
01/01/2009 | US20090005350 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
01/01/2009 | US20090005309 Substituted piperidines |
01/01/2009 | US20090004641 Site-specific labeling of affinity peptides in fusion proteins |
01/01/2009 | US20090004209 4'-O- substituted isoindoline derivatives and compositions comprising and methods of using the same |
01/01/2009 | US20090004185 Amino-substituted quinazoline derivatives as inhibitors of beta-catenin/tcf-4 pathway and cancer treatment agents |
01/01/2009 | US20090000658 2,2-Bipyridine Ligand, Sensitizing Dye and Dye Sensitized Solar Cell |
12/31/2008 | WO2009002469A1 Phthalazine compounds, compositions and methods of use |
12/31/2008 | WO2009001949A1 Pyrazolone derivative |
12/31/2008 | WO2009001942A1 Method for production of 3-hydroxypropan-1-one compound, method for production of 2-propen-1-one compound, and method for production of isoxazoline compound |
12/31/2008 | WO2009001915A1 Substituted imidazole compound and use thereof |
12/31/2008 | WO2009001784A1 N-phenyl-methanamine derivative and pest control agent containing the same |
12/31/2008 | WO2009001730A1 Novel compound having β secretase inhibitory activity |
12/31/2008 | WO2009001132A1 Pyrazinone derivatives and their use in the treatment of lung diseases |
12/31/2008 | WO2009001127A1 Cyanocyclopropylcarboxamides as cathepsin inhibitors |
12/31/2008 | WO2009000878A1 Kallikrein 7 modulators |
12/31/2008 | WO2009000811A1 N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors |
12/31/2008 | WO2009000757A1 Piperazine compounds with herbicidal action |
12/31/2008 | WO2009000756A1 Use of n,n'-bis(1,1-dihydroperfluoro-c3-c5-alkyl)perylene-3,4:9,10-tetracarboxylic diimides |
12/31/2008 | WO2009000753A1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres |
12/31/2008 | WO2009000489A1 Benzimidazole amido derivatives as kinase inhibitors |
12/31/2008 | WO2009000413A1 A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles |
12/31/2008 | WO2009000085A1 Quinoline and quinazoline derivatives useful as modulators of gated ion channels |
12/31/2008 | WO2008140066A3 Pyridone derivatives as p38a mapk inhibitors |
12/31/2008 | WO2008135525A3 Substituted azetidines, manufacturing and use thereof as medicaments |
12/31/2008 | WO2008126933A3 Process for producing pesticidal benzamide compounds |
12/31/2008 | WO2008094690A3 Methods for preparing eszopiclone |
12/31/2008 | WO2008082487A3 Novel jnk inhibitors |
12/31/2008 | WO2008059551A3 Process for the preparation of imatinib and intermediates thereof |
12/31/2008 | WO2008024481A3 3,4-dihydro-2 (1h) - quinolinone and 2 (1h)-quinolinone derivatives |
12/31/2008 | WO2006078753B1 N-substituted heterocyclic sulfonamides |
12/31/2008 | WO2006078753A4 N-substituted heterocyclic sulfonamides |
12/31/2008 | EP2009008A1 Imatinib base, and imatinib mesylate and processes for preparation thereof |
12/31/2008 | EP2009006A1 Ureide derivative and use thereof for medical purposes |
12/31/2008 | EP2008992A1 Aromatic amine derivative and organic electroluminescent device using the same |
12/31/2008 | EP2007789A2 Hcv/hiv inhibitors and their uses |
12/31/2008 | EP2007752A2 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor |
12/31/2008 | EP2007751A1 Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors |
12/31/2008 | EP2007750A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors |
12/31/2008 | EP2007749A2 Tetralines antagonists of the h-3 receptor |
12/31/2008 | EP2007748A2 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives |
12/31/2008 | EP2007747A1 Process for preparing heterocyclic derivatives |
12/31/2008 | EP2007745A2 Fungicide n-cyclopropyl-sulfonylamide derivatives |
12/31/2008 | EP2007734A1 Enzyme inhibitors |
12/31/2008 | EP2007729A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments |
12/31/2008 | EP2007725A2 Non-peptidic renin inhibitors nitroderivatives |
12/31/2008 | EP2007722A1 Adamantane derivatives for the treatment of the metabolic syndrome |
12/31/2008 | EP2007720A1 Benzamide derivatives as inhibitors of histone deacetylase |
12/31/2008 | EP2007719A2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |